NUVB

Nuvation Bio is a drug development company working on cancer treatments that are still in clinical testing. Its main drug candidate, IBTROZI, is designed to treat a type of lung cancer caused by a specific genetic mutation. The company is also testing another drug called Safusidenib for a type of brain tumor, also caused by a genetic mutation. The company was founded in 2018 and is based in New York.